Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP308387.RAyMM0fDzyG3nJkQ8KzWrDsU7On6u2nbf0v-bM1WPai6s130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP308387.RAyMM0fDzyG3nJkQ8KzWrDsU7On6u2nbf0v-bM1WPai6s130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP308387.RAyMM0fDzyG3nJkQ8KzWrDsU7On6u2nbf0v-bM1WPai6s130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP308387.RAyMM0fDzyG3nJkQ8KzWrDsU7On6u2nbf0v-bM1WPai6s130_provenance.
- NP308387.RAyMM0fDzyG3nJkQ8KzWrDsU7On6u2nbf0v-bM1WPai6s130_assertion description "[Overall, erbB2-positive patients had a significantly lower recurrence-free probability than others, 62% at five years as compared to 83%, and showed a significantly decreased breast cancer survival rate (P = 0.0007).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP308387.RAyMM0fDzyG3nJkQ8KzWrDsU7On6u2nbf0v-bM1WPai6s130_provenance.
- NP308387.RAyMM0fDzyG3nJkQ8KzWrDsU7On6u2nbf0v-bM1WPai6s130_assertion evidence source_evidence_literature NP308387.RAyMM0fDzyG3nJkQ8KzWrDsU7On6u2nbf0v-bM1WPai6s130_provenance.
- NP308387.RAyMM0fDzyG3nJkQ8KzWrDsU7On6u2nbf0v-bM1WPai6s130_assertion SIO_000772 11205461 NP308387.RAyMM0fDzyG3nJkQ8KzWrDsU7On6u2nbf0v-bM1WPai6s130_provenance.
- NP308387.RAyMM0fDzyG3nJkQ8KzWrDsU7On6u2nbf0v-bM1WPai6s130_assertion wasDerivedFrom befree-2016 NP308387.RAyMM0fDzyG3nJkQ8KzWrDsU7On6u2nbf0v-bM1WPai6s130_provenance.
- NP308387.RAyMM0fDzyG3nJkQ8KzWrDsU7On6u2nbf0v-bM1WPai6s130_assertion wasGeneratedBy ECO_0000203 NP308387.RAyMM0fDzyG3nJkQ8KzWrDsU7On6u2nbf0v-bM1WPai6s130_provenance.
- befree-2016 importedOn "2016-02-19" NP308387.RAyMM0fDzyG3nJkQ8KzWrDsU7On6u2nbf0v-bM1WPai6s130_provenance.